UBS Group’s Sabra Healthcare REIT SBRA Stock Holding History

UBS Group’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15,000	Closed	-$282K	–	8116
2017 Q4	$282K	Buy	+15,000	New	+$298K	﹤0.01%	4677

Other funds holding SBRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS Group's SBRA Position: Q1 2026 in Review

UBS Group increased its Sabra Healthcare REIT (SBRA) stake by 12% in Q1 2026, buying an estimated $3.48M and bringing the position to 1,636,673 shares worth $31.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

UBS Group first reported a position in SBRA in Q4 2014 and has held it in 46 quarters since. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

UBS Group held 1,636,673 shares of Sabra Healthcare REIT worth $31.5M as of Q1 2026.
UBS Group bought 176,454 Sabra Healthcare REIT shares in Q1 2026, an estimated $3.48M.
Sabra Healthcare REIT made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2114 holding.
UBS Group first reported a position in Sabra Healthcare REIT in Q4 2014 and has held it in 46 quarters since.
459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.